Home/About/Expertise/Our Team of Experts

Have Questions?

Global Headquarters

Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157

North America

Tel: 1-617-573-9450
Fax: 1-617-573-9542


Tel: +81 (0)80-1164-4754

Request a Demo

What our customers are saying

When I think of the future, I think of EvaluatePharma

Senior Director,
Global pharmaceutical company

Key Experts

Analyst Team

Anthony Raeside, Head of Research

Mr. Raeside leads Evaluate's analyst teams, currently numbering over 95 staff globally, providing life science sector analysis and commercial insight into the biotechnology, pharmaceutical and medical device industries. He joined EvaluatePharma in 1997 and has been responsible for content development and strategy, to continually enhance the value of Evaluate services to its client base. He is an economics graduate of the London School of Economics and Political Science. Anthony Raeside

Ian Strickland, Senior Product Manager

Ian Strickland Mr. Strickland started with Evaluate in 2000 after graduating from the University of Nottingham in the UK. After serving as an Analyst he held the role of Product Manager of EvaluatePharma from 2007-2008. He also worked for Propagate Pharma as Senior Business Analyst before returning to Evaluate in 2010. Following his return he initially focused on data and analytical development and implementation of Evaluate’s Clinical Trials and MedTech offering and became the Product Manager of the latter. Since January 2017 he transitioned back to Evaluate’s pharmaceutical offering and is currently working as a Senior Product Manager.


Antonio Iervolino, Head of Forecasting 

Mr Iervolino joined Evaluate in 2015 as Head of Forecasting. A strategy executive with extensive background in the healthcare and life sciences sector, Mr Iervolino spent 3 years at Mundipharma International in various senior roles focused on strategy and market access. Prior to that he was at IMS Consulting Group where he led multiple international projects on portfolio strategy, global launches and go-to-market optimization. Mr Iervolino’s educational background in Business Management includes extensive education in R&D strategy and innovation (INSEAD, MIT).

Dr Paul Verdin - Head of Custom Services

Mr Verdin leads the Evaluate Custom Services team, providing data- and insight-driven solutions to clients across the pharma industry including at major pharma, biotechs, generics, CMOs/CROs, and other industry-allied organisations.  Paul and his team work very closely with client organisations to understand the key challenges they face, and to design custom project frameworks based on a foundation of Evaluate data to help address them.  With more than a decade of experience from laboratory research to consulting, Paul was previously Managing Consultant in the Thomson Reuters Life Sciences Professional Services group and Portfolio Manager at CMR International. Paul’s background is in biological sciences with a BSc in Biology and PhD in neuropharmacology from the University of Nottingham.

Jonathan Moser, Services Delivery Lead

Mr. Moser has over eight years in-house experience at Evaluate specializing in forecast, financial and epidemiological data. He takes an active role in product development and was instrumental in the development and introduction of EvaluatePharma’s Sales by Indication, Epidemiology data and Indication Overviews. He is a graduate of Warwick University.

EP Vantage Team

EP Vantage’s award-winning editorial team consists of:

Lisa Urquhart, Editor

A journalist with more than a decade of experience, Lisa joined Evaluate's EP Vantage editorial team after a solid career at the Financial Times in London, including time as biotechnology correspondent. She generated a number of exclusive reports during her seven years at the Financial Times. An active contributor to industry panels, Lisa has also commented on the pharmaceutical industry on both television and radio.
Email: lisau@epvantage.com
Twitter: @ByLisaU
Lisa Urquhart

Amy Brown, Special Reports and Projects Editor

Amy Brown Amy joined EP Vantage from Thomson Financial News, where she covered the European pharmaceutical and biotechnology sectors for several years. She has extensive experience working as a financial journalist, working for companies including Bloomberg News, and has been a contributor to publications such as Corporate Financier and the Sunday Times.
Email: amyb@epvantage.com
Twitter: @ByAmyBrown

Jonathan Gardner, Reporter

Jonathan joined Vantage having worked as a freelance journalist for a number of respected healthcare publications, including Elsevier Global Medical News. Jonathan also served as communications manager for Health Affairs Journal and as bureau chief for Modern Healthcare. After seven years in Vantage’s London office, Jonathan is now based in Virginia where he extends the editorial reach of Vantage with his wealth of knowledge on the US primary healthcare market and regulatory affairs. Email: jonathang@epvantage.com
Twitter: @ByJonGardner
Jonathan Gardner

Jacob Plieth, Senior Reporter 

Jacob Plieth Jacob has 21 years' experience of writing about healthcare, and joined Vantage in 2012 from Edison Investment Research, where he spent five years as an equity research analyst. He has also worked at Dow Jones and the Wall Street Journal. A biochemist by training, Jacob has spoken about pharmaceuticals and other topics on the BBC World Service and News 24, as well as contributing to various publications including Investors Chronicle and Mednous.
Email: jacobp@epvantage.com
Twitter: @JacobPlieth

Elizabeth Cairns, Medtech Reporter

Having started her publishing career with a focus on the biotech and pharmaceutical sectors, Elizabeth pivoted to covering the medical device industry around ten years ago. She has been Vantage’s Medtech reporter for five years now, and has been interviewed by publications including the Financial Times and the Boston Globe as an expert on the sector.
Email: elizabethc@epvantage.com
Twitter: @LizVantage

Elizabeth Cairns

Madeleine Armstrong, Reporter

Joanne Fagg Madeleine is a reporter at Vantage covering both the pharma and Medtech industries. She joined in 2015 after over eight years at Informa, most recently as Deputy Editor of Clinica Medtech Intelligence. Before this, she also covered the pharmaceutical sector as a reporter for Scrip.
Email: MadeleineA@epvantage.com
Twitter: @ByMadeleineA

Edwin Elmhirst, Data Journalist

Edwin has under- and postgraduate degrees in biomedical science as well as prior freelance experience in editing scientific publications. He is responsible for a variety of behind-the-scenes functions that go into the day-to-day running of Vantage, including data handling and analysis.
Email: EdwinE@epvantage.com
Twitter: @EdwinElmhirst

Elizabeth Cairns

Joanne Fagg, Content Manager

Joanne Fagg Joanne has an MSc in Molecular Medicine from Imperial College London and has previous experience working in Research & Development for a biopharmaceutical company. She has also worked in healthcare publishing and communications. Responsible for the smooth running of EP Vantage’s social media efforts and electronic publications, Joanne is increasing her understanding of the pharmaceutical industry by working and supporting members of the EP Vantage team.
Email: joannef@epvantage.com
Twitter: @JoEPVantage